Mature B-Cell Non-Hodgkin Lymphoma — Trials

Mature B-Cell Non-Hodgkin Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

2,506 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 792
Recruiting: 399
Ph III recruiting: 39
Growth YoY: +8%
Industry share: 24%
Top sponsor: National Cancer Institute (NCI)
Termination share: 36.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (393)

clinicaltrialsPublishedShowing 1,101–1,150 of 2,506 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03955783	Venetoclax and Selinexor in Treating Patients with Relapsed or Refractory High Risk Hematologic Malignancies	completed	Phase 1	78	Sanjay MohanOTHER	1	Oct 26, 2024	clinicaltrials
NCT03311126	Bendamustine + Obinutuzumab Induction With Obinutuzumab Maintenance in Untreated Mantle Cell Lymphoma	terminated	Phase 2	21	University of Wisconsin, MadisonOTHER	1	Oct 24, 2024	clinicaltrials